These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 29201040)

  • 1. Caffeoylquinic Acid-Rich Extract of
    Lee YJ; Jang YN; Han YM; Kim HM; Jeong JM; Son MJ; Jin CB; Kim HJ; Seo HS
    PPAR Res; 2017; 2017():3912567. PubMed ID: 29201040
    [No Abstract]   [Full Text] [Related]  

  • 2. Corrigendum to "Caffeoylquinic Acid-Rich Extract of
    Lee YJ; Jang YN; Han YM; Kim HM; Jeong JM; Son MJ; Jin CB; Kim HJ; Seo HS
    PPAR Res; 2019; 2019():5317126. PubMed ID: 31781179
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fimasartan Ameliorates Nonalcoholic Fatty Liver Disease through PPAR
    Lee YJ; Jang YN; Han YM; Kim HM; Jeong JM; Seo HS
    PPAR Res; 2017; 2017():8048720. PubMed ID: 28386270
    [TBL] [Abstract][Full Text] [Related]  

  • 4.
    Lee YJ; Jang YN; Han YM; Kim HM; Seo HS; Kim HJ; Jung TW; Jeong JH; Abd El-Aty AM; Jung KO
    J Med Food; 2024 Jun; 27(6):521-532. PubMed ID: 38651680
    [TBL] [Abstract][Full Text] [Related]  

  • 5.
    Lee YJ; Jang YN; Han YM; Kim HM; Jin C; Kim HJ; Seo HS
    Evid Based Complement Alternat Med; 2018; 2018():9616574. PubMed ID: 30622619
    [No Abstract]   [Full Text] [Related]  

  • 6.
    Lee H; Kim HJ; Chae H; Yoon NE; Jung BH
    Plants (Basel); 2021 Oct; 10(11):. PubMed ID: 34834649
    [No Abstract]   [Full Text] [Related]  

  • 7. Free radical biology for medicine: learning from nonalcoholic fatty liver disease.
    Serviddio G; Bellanti F; Vendemiale G
    Free Radic Biol Med; 2013 Dec; 65():952-968. PubMed ID: 23994574
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Monascin and ankaflavin act as natural AMPK activators with PPARα agonist activity to down-regulate nonalcoholic steatohepatitis in high-fat diet-fed C57BL/6 mice.
    Hsu WH; Chen TH; Lee BH; Hsu YW; Pan TM
    Food Chem Toxicol; 2014 Feb; 64():94-103. PubMed ID: 24275089
    [TBL] [Abstract][Full Text] [Related]  

  • 9. n-3 Polyunsaturated fatty acids for the management of alcoholic liver disease: A critical review.
    Wang M; Ma LJ; Yang Y; Xiao Z; Wan JB
    Crit Rev Food Sci Nutr; 2019; 59(sup1):S116-S129. PubMed ID: 30580553
    [TBL] [Abstract][Full Text] [Related]  

  • 10. LB100 ameliorates nonalcoholic fatty liver disease
    Chen XY; Cai CZ; Yu ML; Feng ZM; Zhang YW; Liu PH; Zeng H; Yu CH
    World J Gastroenterol; 2019 Dec; 25(45):6607-6618. PubMed ID: 31832001
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protective effect and mechanism of Qiwei Tiexie capsule on 3T3-L1 adipocytes cells and rats with nonalcoholic fatty liver disease by regulating LXRα, PPARγ, and NF-κB-iNOS-NO signaling pathways.
    Suolang PC; Liu BQ; Chen J; De J; Nima ZB; Dunzhu CR
    J Ethnopharmacol; 2019 May; 236():316-325. PubMed ID: 30851372
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mechanism of the development of nonalcoholic steatohepatitis after pancreaticoduodenectomy.
    Nagaya T; Tanaka N; Kimura T; Kitabatake H; Fujimori N; Komatsu M; Horiuchi A; Yamaura T; Umemura T; Sano K; Gonzalez FJ; Aoyama T; Tanaka E
    BBA Clin; 2015 Jun; 3():168-74. PubMed ID: 26674248
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulation of energy metabolism by long-chain fatty acids.
    Nakamura MT; Yudell BE; Loor JJ
    Prog Lipid Res; 2014 Jan; 53():124-44. PubMed ID: 24362249
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Methionine restriction prevents the progression of hepatic steatosis in leptin-deficient obese mice.
    Malloy VL; Perrone CE; Mattocks DA; Ables GP; Caliendo NS; Orentreich DS; Orentreich N
    Metabolism; 2013 Nov; 62(11):1651-61. PubMed ID: 23928105
    [TBL] [Abstract][Full Text] [Related]  

  • 15.
    Park M; Yoo JH; Lee YS; Lee HJ
    Nutrients; 2019 Feb; 11(3):. PubMed ID: 30813654
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alisol A 24-Acetate Prevents Hepatic Steatosis and Metabolic Disorders in HepG2 Cells.
    Zeng L; Tang W; Yin J; Feng L; Li Y; Yao X; Zhou B
    Cell Physiol Biochem; 2016; 40(3-4):453-464. PubMed ID: 27889747
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rutin exhibits hepatoprotective effects in a mouse model of non-alcoholic fatty liver disease by reducing hepatic lipid levels and mitigating lipid-induced oxidative injuries.
    Liu Q; Pan R; Ding L; Zhang F; Hu L; Ding B; Zhu L; Xia Y; Dou X
    Int Immunopharmacol; 2017 Aug; 49():132-141. PubMed ID: 28577437
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Water Extract of
    Mun J; Kim S; Yoon HG; You Y; Kim OK; Choi KC; Lee YH; Lee J; Park J; Jun W
    Nutrients; 2019 Oct; 11(10):. PubMed ID: 31640183
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatoprotective Effects of Soybean Embryo by Enhancing Adiponectin-Mediated AMP-Activated Protein Kinase α Pathway in High-Fat and High-Cholesterol Diet-Induced Nonalcoholic Fatty Liver Disease.
    Hong J; Kim S; Kim HS
    J Med Food; 2016 Jun; 19(6):549-59. PubMed ID: 27266339
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aqueous Extract of Pepino (
    Hsu JY; Lin HH; Hsu CC; Chen BC; Chen JH
    Nutrients; 2018 Jul; 10(7):. PubMed ID: 30037014
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.